A randomized, double-blind, placebo-and active comparator (pregabalin)-controlled phase II study of DS-5565 for the treatment of diabetic peripheral neuropathic pain

Authors
Category Primary study
ConferenceDiabetes
Year 2014
This article has no abstract
Epistemonikos ID: 3db94cb8604f3be70976e50a91ba56b3be8e9b76
First added on: Apr 30, 2026